| Income Statement |
| Total Revenue | 2.30B |
|
| Revenues (USD) | 338.57M |
| Cost of Revenue | 2.17B |
| Gross Profit | 132.27M |
| Operating Expenses | 155.52M |
| Research and Development Expense | 19.03M |
| Selling, General and Administrative Expense | 75.69M |
| Operating Income | -23.24M |
| Interest Expense | 8.89M |
| Net Income | -39.13M |
| Net Income Common Stock | -39.13M |
| Net Income Common Stock (USD) | -5.76M |
| Consolidated Income | -31.65M |
| Net Income to Non-Controlling Interests | 7.48M |
| Earning Before Interest & Taxes (EBIT) | -30.25M |
| Earning Before Interest & Taxes (USD) | -4.45M |
| Weighted Average Shares | 176.46M |
| Weighted Average Shares Diluted | 176.46M |
| Balance Sheet |
| Cash and Equivalents | 321.11M |
| Cash and Equivalents (USD) | 47.27M |
| Investments | 134.81M |
| Investments Current | 134.81M |
| Trade and Non-Trade Receivables | 183.03M |
| Current Assets | 1.72B |
| Property, Plant & Equipment Net | 57.27M |
| Total Assets | 1.79B |
| Debt Current | 260.00M |
| Total Debt | 281.98M |
| Current Liabilities | 1.61B |
| Debt Non-Current | 21.98M |
| Total Liabilities | 1.63B |
| Accumulated Retained Earnings (Deficit) | -4.03B |
| Accumulated Other Comprehensive Income | 71.45M |
| Shareholders Equity | -755.27M |
| Shareholders Equity (USD) | -111.17M |
| Assets Non-Current | 65.81M |
| Total Debt (USD) | 41.51M |
| Goodwill and Intangible Assets | 713.00K |
| Inventory | 896.69M |
| Liabilities Non-Current | 24.16M |
| Trade and Non-Trade Payables | 1.08B |
| Cash Flow |
| Net Cash Flow from Financing | -2.89M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -55.48M |
| Net Cash Flow from Investing | -40.85M |
| Net Cash Flow from Operations | -11.44M |
| Effect of Exchange Rate Changes on Cash | -295.00K |